Claim Missing Document
Check
Articles

Found 2 Documents
Search

Religiosity, Spirituality, and Nonsuicidal Self-Injury Among Adolescents: A Meta-Analysis of Cross-Sectional and Longitudinal Studies Maya Aulya Saputri; Andrian Fajar Kusumadewi; Soewadi
Community Medicine and Education Journal Vol. 7 No. 1 (2025): Community Medicine and Education Journal
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/cmej.v7i1.881

Abstract

Nonsuicidal self-injury (NSSI) represents a growing public health concern among adolescents worldwide, with prevalence rates reaching 44.8% in Asian populations. Spirituality and religiosity have been proposed as protective factors against self-injurious behaviours; however, the quantitative evidence for this association has not been systematically synthesised with rigorous methodological standards. This meta-analysis aimed to evaluate the association between spirituality/religiosity and self-injurious behaviours in adolescents and young adults, and to clarify distinctions between NSSI and suicidal behaviour. A systematic search of multiple databases (PubMed, PsycINFO, CINAHL, Web of Science) was conducted using predefined search terms related to spirituality, religiosity, religion, self-injury, self-harm, NSSI, and adolescent populations. Original research articles reporting quantitative data on the association between spirituality/religiosity and self-injurious behaviours were included. Ten studies met inclusion criteria for qualitative synthesis, of which six provided sufficient quantitative data for meta-analysis. Effect sizes were converted to standardised mean differences (Hedges' g) and pooled using a random-effects model (DerSimonian-Laird). Risk of bias was assessed using an adapted Newcastle-Ottawa Scale. Prediction intervals (PI) were calculated alongside 95% confidence intervals (CI). The pooled standardised mean difference was −0.67 (95% CI: −1.12 to −0.21; 95% PI: −2.18 to 0.85; p = 0.004), indicating a protective effect of spirituality/religiosity against self-harm. Substantial heterogeneity was observed (I² = 96%; τ² = 0.30), reflecting variability in study designs, populations, outcome measures, and religiosity constructs. Sensitivity analyses confirmed directional consistency of findings, though studies differ considerably in effect magnitude. Subgroup analyses identified potential differences by study design (cross-sectional vs. longitudinal) and geographic region, though these require cautious interpretation given limited sample numbers (k = 6). Meta-regression was limited by small sample size and collinearity between study characteristics. In conclusion, spirituality and religiosity demonstrated a protective association with reduced self-injurious behaviours among adolescents and young adults. However, the substantial heterogeneity, predominantly observational evidence base, concentration in Western populations, and inability to distinguish NSSI from suicidal behaviour in all studies necessitate cautious interpretation. These findings support further investigation of spiritual assessment in adolescent mental health, though clinical implications must be tempered by methodological limitations. Well-designed prospective studies examining cultural context, mechanisms of action, and distinctions between NSSI phenotypes are required.
Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled Trials Siti Nashria Rusdhy; Andrian Fajar Kusumadewi; Carla Raymondalexas Marchira; Mustika Suci Mahardikaningrum; Teresa Lalita Wiryarini; Devira Ayu Wulandari
Open Access Indonesian Journal of Medical Reviews Vol. 6 No. 2 (2026): Open Access Indonesian Journal of Medical Reviews
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/oaijmr.v6i2.883

Abstract

Psilocybin-assisted therapy shows promise for depression, though current evidence relies on Phase 2 trials with notable methodological limitations. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating psilocybin-assisted therapy for major or treatment-resistant depression up to February 2024. We evaluated depressive symptom severity using random-effects meta-analysis, moderator analyses, Cochrane Risk of Bias 2, and GRADE methodology. Nine RCTs (N=514) were included. Psilocybin therapy demonstrated a large pooled effect size for symptom reduction (SMD = 1.270, 95% CI: 0.865–1.676, p<0.001). However, substantial heterogeneity was observed (I² = 79.1%). Comparator type significantly moderated outcomes, with waitlist controls showing substantially larger effects than active/placebo controls. Overall GRADE certainty of evidence was rated LOW due to risk of bias, heterogeneity, short-term outcomes, and publication bias concerns. In conclusion, while psilocybin-assisted therapy yields a large pooled effect estimate for depression, current findings are preliminary. Results are heavily qualified by methodological constraints, including waitlist-inflated efficacy, compromised blinding from subjective psychedelic effects, and the confounding influence of integrated psychological support. Confirmation through robust Phase 3 trials is required before supporting routine clinical implementation.